These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 18226577)

  • 1. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line.
    Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P
    Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of STAT-1 inhibition and induction of cytokine resistance in pancreatic β cells treated with St John's wort and its component hyperforin.
    Novelli M; Beffy P; Gregorelli A; Porozov S; Mascia F; Vantaggiato C; Masiello P; Menegazzi M
    J Pharm Pharmacol; 2019 Jan; 71(1):93-103. PubMed ID: 28990659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. St. John's wort extract and hyperforin inhibit multiple phosphorylation steps of cytokine signaling and prevent inflammatory and apoptotic gene induction in pancreatic β cells.
    Novelli M; Menegazzi M; Beffy P; Porozov S; Gregorelli A; Giacopelli D; De Tata V; Masiello P
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):92-104. PubMed ID: 27780755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. St. John's wort extract and hyperforin protect rat and human pancreatic islets against cytokine toxicity.
    Novelli M; Beffy P; Menegazzi M; De Tata V; Martino L; Sgarbossa A; Porozov S; Pippa A; Masini M; Marchetti P; Masiello P
    Acta Diabetol; 2014 Feb; 51(1):113-21. PubMed ID: 24121871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Role of St. John's Wort and Its Components Hyperforin and Hypericin against Diabetes through Inhibition of Inflammatory Signaling: Evidence from In Vitro and In Vivo Studies.
    Novelli M; Masiello P; Beffy P; Menegazzi M
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.
    Zhou C; Tabb MM; Sadatrafiei A; Grün F; Sun A; Blumberg B
    J Clin Immunol; 2004 Nov; 24(6):623-36. PubMed ID: 15622447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines.
    Hostanska K; Reichling J; Bommer S; Weber M; Saller R
    Eur J Pharm Biopharm; 2003 Jul; 56(1):121-32. PubMed ID: 12837490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperforin is a modulator of inducible nitric oxide synthase and phagocytosis in microglia and macrophages.
    Kraus B; Wolff H; Elstner EF; Heilmann J
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):541-53. PubMed ID: 20369228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort.
    Hu ZP; Yang XX; Chen X; Cao J; Chan E; Duan W; Huang M; Yu XQ; Wen JY; Zhou SF
    Curr Drug Metab; 2007 Feb; 8(2):157-71. PubMed ID: 17305494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro.
    Capasso R; Borrelli F; Capasso F; Mascolo N; Izzo AA
    Urology; 2004 Jul; 64(1):168-72. PubMed ID: 15245964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of serotoninergic 5-HT1A/2A, alpha-adrenergic and dopaminergic D1 receptors in St. John's wort-induced prepulse inhibition deficit: a possible role of hyperforin.
    Tadros MG; Mohamed MR; Youssef AM; Sabry GM; Sabry NA; Khalifa AE
    Behav Brain Res; 2009 May; 199(2):334-9. PubMed ID: 19136030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the antidepressant St. John's wort (Hypericum perforatum) on rat and human vas deferens contractility.
    Capasso R; Borrelli F; Montanaro V; Altieri V; Capasso F; Izzo AA
    J Urol; 2005 Jun; 173(6):2194-7. PubMed ID: 15879886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W; Schober F; Mannel M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of β1 -adrenergic receptors in rat C6 glioblastoma cells by hyperforin and hyperoside from St John's wort.
    Jakobs D; Hage-Hülsmann A; Prenner L; Kolb C; Weiser D; Häberlein H
    J Pharm Pharmacol; 2013 Jun; 65(6):907-15. PubMed ID: 23647684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. St. John's wort: role of active compounds for its mechanism of action and efficacy.
    Butterweck V; Schmidt M
    Wien Med Wochenschr; 2007; 157(13-14):356-61. PubMed ID: 17704987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proapoptotic and prepulse inhibition (PPI) disrupting effects of Hypericum perforatum in rats.
    Tadros MG; Mohamed MR; Youssef AM; Sabry GM; Sabry NA; Khalifa AE
    J Ethnopharmacol; 2009 Apr; 122(3):561-6. PubMed ID: 19171186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models.
    Butterweck V; Christoffel V; Nahrstedt A; Petereit F; Spengler B; Winterhoff H
    Life Sci; 2003 Jun; 73(5):627-39. PubMed ID: 12770617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA receptor-antagonistic properties of hyperforin, a constituent of St. John's Wort.
    Kumar V; Mdzinarishvili A; Kiewert C; Abbruscato T; Bickel U; van der Schyf CJ; Klein J
    J Pharmacol Sci; 2006 Sep; 102(1):47-54. PubMed ID: 16936454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.